Table 1.
Summary of selected randomized controlled trials.
| Reference | Location (Language) |
Participant Characteristics | Intervention Program | Wuqinxi Training | Outcome Measured |
Adverse Event; Follow-Up |
||||
|---|---|---|---|---|---|---|---|---|---|---|
| Sample Size (AT) | Mean Age or Age Range | Course of Disease (year) | Frequency (weekly) |
Time (min) |
Duration (week) |
|||||
| Chen, et al. (2015) [19] | Anhui, China (Chinese) | 100 (10.34%) | WQ: 58.66 (7.56) CG: 58.64(7.52) |
14.52 (5.96) | WQ: Wuqinxi CG: Usual Care |
4 | 30 | 24 | Quality of life (CAT) | No; No |
| He et al. (2015) [20] | Anhui, China (Chinese) | 93 (7.00%) | WQ: 58.66 (7.56) CG: 58.64 (7.52) |
14.52 (5.96) | WQ: Wuqinxi + Drug Therapy CG: Drug Therapy |
4 | 30 | 24 | Quality of life (ZSH) | No; No |
| Gao et al. (2016) [21] | Guangdong, China (Chinese) | 74 (2.70%) | WQ: 67.14 (9.08) CG: 66.03 (8.18) |
WQ: 13.69 (5.67) CG: 14.78 (9.24) |
WQ: Wuqinxi + Drug Therapy CG: Breathing training + Drug Therapy |
14 | 30 | 24 | Lung function (FEV1, FEV1%, FEV1/FVC) Exercise Capacity (6-MWT) |
No; No |
| Tan et al. (2017) [22] | Guangdong, China (Chinese) | 100 (0%) | WQ: 67.72 (9.26) CG: 74.24 (9.10) |
NR | WQ: Wuqinxi CG: NR |
7 | 45 | 24 | Quality of life (CCQ) | No; No |
| Wei et al. (2015) [23] | Anhui, China (Chinese) | 93 (7.00%) | WQ: 58.66 (7.56) CG: 58.64 (7.52) |
14.52 (5.96) | WQ: Wuqinxi + Drug Therapy CG: Drug Therapy |
4 | 30 | 24 | Lung function (FEV1%, FEV1/FVC) |
No; No |
| Xing et al. (2017) [24] | Tainting, China (Chinese) | 93 (0%) | WQ: 57.58 (7.47) TC: 59.00 (7.84) |
WQ: 7.96 (1.36) TC: 7.25 (1.58) |
WQ: Wuqinxi TC: Tai chi |
4 | 45 | 12 | Exercise Capacity (6-MWT) Lung function (FEV1%, FEV1/FVC), Quality of life (CCQ) |
No; No |
| Zhao et al. (2015) [25] | Zhengzhou, China (Chinese) | 60 (0%) | WQ: 58.91 (5.86) CG: 56.66 (6. 43) |
WQ: 6.81 (2.34) CG: 6.52 (2.42) |
WQ: Wuqinxi CG: Drug Therapy |
3 | 40 | 12 | Lung function (FEV1, FEV1%, FEV1/FVC), Exercise Capacity (6-MWT) |
No; No |
| Zhu et al. (2010) [26] | Nanjing, China (Chinese) | 74 (5.12%) | WQ: 53.53 (10.05) WT: 55.12 (11.41) CG: 55.46 (9.87) |
NR | WQ: Wuqinxi + Usual Care WT: Walking training + Usual Care CG: Usual Care |
7 | 45 | 12 | Lung function (FEV1, FEV1%, FEV1/FVC) Exercise Capacity (6-MWT) |
No; No |
Note: AT = attrition rate; WQ = Wuqinxi; CG = control group; TC = Tai chi; WT = Walking training; FEV1 = the forced expiratory volume in one second;FEV1% = percentage of the forced expiratory volume in one second; FEV1/FVC = the amount of air exhaled in the first second divided by all of the air exhaled during a maximal exhalation; 6-MWT = 6-Minute Walking Test; CCQ = Clinical Chronic Obstructive Pulmonary Disease Questionnaire; CAT = COPD Assessment Test; QLA (ZSH) = Quality of Life Assessment Form scored by Zhongshan Hospital.